Clinical Trials Directory

Trials / Completed

CompletedNCT06789185

Effects of Esketamine at Subanesthetic Dose on Emergence Delirium in Preschool Children Undergoing Ambulatory Laparoscopic Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
96 (actual)
Sponsor
Qiu jinpeng · Academic / Other
Sex
All
Age
24 Months – 71 Months
Healthy volunteers
Not accepted

Summary

Emergence delirium (ED) is a manifestation of acute postoperative brain dysfunction that occurs with a relatively high frequency after pediatric anesthesia. The incidence varies depending on the diagnostic criteria used and the combination of administered anesthetic drugs. The goal of this clinical trial is to investigate whether a subanesthetic dose of esketamine can reduce incidence of ED.

Conditions

Interventions

TypeNameDescription
DRUG0.1mg/kg esketamineIntravenous injection 0.1mg/kg esketamine about 5min before the end of the surgery
DRUG0.2mg/kg esketamineIntravenous injection 0.2mg/kg esketamine about 5min before the end of the surgery
DRUG0.1ml/kg normal salineIntravenous injection 0.1ml/kg normal saline about 5min before the end of the surgery

Timeline

Start date
2025-02-07
Primary completion
2025-05-16
Completion
2025-05-16
First posted
2025-01-23
Last updated
2025-05-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06789185. Inclusion in this directory is not an endorsement.

Effects of Esketamine at Subanesthetic Dose on Emergence Delirium in Preschool Children Undergoing Ambulatory Laparoscop (NCT06789185) · Clinical Trials Directory